Provectus Pharmaceuticals, Inc. Stock OTC Bulletin Board
Equities
PVCT
US74373F1003
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | 0.99 1.35 | Sales 2023 | 0.56 0.76 | Capitalization | 40.27M 54.89M |
---|---|---|---|---|---|
Net income 2022 | -3M -4.09M | Net income 2023 | -3M -4.09M | EV / Sales 2022 | 48,121,944 x |
Net Debt 2022 | 2.16M 2.95M | Net Debt 2023 | 2.95M 4.02M | EV / Sales 2023 | 77,502,175 x |
P/E ratio 2022 |
-12.8
x | P/E ratio 2023 |
-13
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.58% |
Managers | Title | Age | Since |
---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 71 | 18-04-26 |
Eric A. Wachter
FOU | Founder | 61 | 01-12-31 |
Heather Raines
DFI | Director of Finance/CFO | 58 | 17-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric A. Wachter
FOU | Founder | 61 | 01-12-31 |
John W. Lacey
BRD | Director/Board Member | 76 | 18-04-26 |
President | 55 | 17-04-02 |
1st Jan change | Capi. | |
---|---|---|
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.35% | 21.25B | |
-5.57% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- PVCT Stock
- PVCT Stock